THREE YEAR OUTCOMES BY DONOR TYPE IN PHASE III STUDIES OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT AND BENEFIT-EXT)

被引：0

作者：

Florman, S. ^{[1
]}

Becker, T. ^{[2
]}

Bresnahan, B. ^{[3
]}

Chevaile-Ramos, A. ^{[4
]}

Carvalho, D. ^{[5
]}

Muehlbacher, F. ^{[6
]}

O'Connell, P. ^{[7
]}

Duan, T. ^{[8
]}

Agarwal, M. ^{[8
]}

Larsen, C. ^{[9
]}

机构：

[1] Mt Sinai Med Ctr, New York, NY 10029 USA

[2] Hannover Med Sch, D-30623 Hannover, Germany

[3] Univ Wisconsin, Milwaukee, WI 53201 USA

[4] Cent Hosp, Potosi, Mexico

[5] Hosp Geral Bonsuccesso, Rio De Janeiro, Brazil

[6] Univ Klin Chirurg, Vienna, Austria

[7] Westmead Hosp, Westmead, NSW, Australia

[8] Bristol Myers Squibb Co, Princeton, NJ USA

[9] Emory Univ, Med Ctr, Atlanta, GA 30322 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：51 / 51

页数：1